A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine

NCT00735475 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1268

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: CSL Limited Influenza Virus Vaccine (Afluria®)
BIOLOGICAL: US Licensed Influenza Virus Vaccine (Fluzone®)

Sponsor

Seqirus